Cargando…
Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
The L-type calcium channel blocker fendiline has been shown to interfere with Ras-dependent signaling in K-Ras mutant cancer cells. Earlier studies from our lab had shown that treatment of pancreatic cancer cells with fendiline causes significant cytotoxicity and interferes with proliferation, survi...
Autores principales: | Alhothali, Marwa, Mathew, Mevin, Iyer, Geeta, Lawrence, Harshani R., Yang, Shengyu, Chellappan, Srikumar, Padmanabhan, Jaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567171/ https://www.ncbi.nlm.nih.gov/pubmed/31100813 http://dx.doi.org/10.3390/ijms20102423 |
Ejemplares similares
-
Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling
por: Woods, Neha, et al.
Publicado: (2015) -
Combatting PDAC with two tumor-targeting small RNAs
por: Kasinski, Andrea L.
Publicado: (2019) -
Scaling the immune incline in PDAC
por: Rojas, Luis A., et al.
Publicado: (2021) -
Transverse Space Charge Effect During Bunch Compression in PDAC1 and PDAC2 Compressor Ring
por: Franchetti, Giuliano
Publicado: (2000) -
The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020)